The ferocity of China’s biopharmaceutical investment boom this year – fuelled by record-breaking licensing of commercial rights to global giants…
Read More »Biotechnology
Mainland China’s commercial and financial hub Shanghai has pledged to remove all regulatory hurdles for foreign investors to set up…
Read More »
Eleven Chinese healthcare and biotechnology companies filed applications to list on the Hong Kong stock exchange in the last two…
Read More »
Shenzhen-based XtalPi posted a 615 per cent surge in first-half revenue from its drug-discovery business following a blockbuster deal that…
Read More »
In their op-ed in The New York Times, economists David Autor and Gordon Hanson – whose work first defined the…
Read More »
China will need to achieve annual gross domestic product growth of at least 4.5 per cent over the next five…
Read More »
Thematic exchange-traded funds (ETFs) tracking Hong Kong-listed artificial intelligence (AI) and biotechnology firms could be listed on the Saudi Exchange,…
Read More »
When the stock markets in Hong Kong and mainland China resumed trading after a long weekend on Monday, traders knew…
Read More »
HutchMed aims to establish a bigger presence in the city when the first wet laboratories at the much larger Hong…
Read More »
China’s government and the market must work together to develop “new quality productive forces” to compete with other major countries,…
Read More »